The U.S. Court dismissed the Celltrion’s claim to nullify the patent of Ramicade

The U.S. Court dismissed the patent nullity action for the rheumatoid arthritis treatment ‘Remicade’, which was filed by Celltrion.

According to the industry concerned on the 7^th, the U.S. court made a judgment to dismiss the Celltrion’s DJ action claim to nullify the patent of the Janssen’s Remicade on the last 3^rd.

The judgment of the court was that an independent claim is impossible over t...